Terns Pharmaceuticals, Inc. · NASDAQ:TERN
Adage Capital Management, L.P.'s stake in Terns Pharmaceuticals, Inc. fell to 1.84% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 13, 2026
Adage Capital Management, L.P.'s stake in Terns Pharmaceuticals, Inc. fell to 1.84%, 2,124,817 shares, as a passive investor on Mar 31, 2026. Filed May 13, 2026 (Schedule 13G/A).
- Stake
- 1.84%
- Shares
- 2,124,817
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 1.84% | 2,124,817 |
| Robert Atchinson | 1.84% | 2,124,817 |
| Phillip Gross | 1.84% | 2,124,817 |
Source
Related
- Terns Pharmaceuticals, Inc.
- Adage Capital Management, L.P.
- Terns Pharmaceuticals, Inc. shareholders
- Schedule 13G · Adage Capital Management, L.P. · Feb 12, 2026
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Form 4 · Kuriakose Emil · May 5, 2026
- Form 4 · Gengos Andrew · May 5, 2026
- Form 4 · Burroughs Amy L. · May 5, 2026